In addition, a recent retrospective analysis of anakinra and canakinumab in kidney transplant recipients suffering from FMF demonstrated prolonged graft survival and lower rejection supporting renal benefits of IL-1 inhibition (155). Here, IL1B is linked to familial Mediterranean fever.